Literature DB >> 6488445

Bronchopulmonary effects of elliptinium in anesthetized dogs.

A Eschalier, J Lavarenne, M Renoux.   

Abstract

The bronchoconstrictor effect of elliptinium already demonstrated in the guinea-pig is shown in the dog. It is less intense and its onset is prompter. Successive administration of identical doses of elliptinium attenuates the bronchospasm induced, suggesting tachyphylaxis. The previously described indirect bronchoconstrictor effect involving endogenous mediators seems also to be active in these circumstances.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6488445     DOI： 10.1007/bf00269039

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


  3 in total

1.  Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

Authors:  P Juret; A Tanguy; A Girard; J Y Le Talaer; J S Abbatucci; N Dat-Xuong; J B Le Pecq; C Paoletti
Journal:  Eur J Cancer       Date:  1978-02       Impact factor: 9.162

2.  [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].

Authors:  J Rouesse; T Tursz; T Le Chevalier; D Huertas; J L Amiel; G Brule; B Callet; J P Droz; P M Voisin; H Sancho-Garnier; J B Le Pecq; C Paoletti
Journal:  Nouv Presse Med       Date:  1981-05-30

3.  Histamine-releasing properties of hydroxy-9-methyl-2-ellipticinium acetate.

Authors:  A Eschalier; C Advenier; B Lebel; C Burtin; J Lavarenne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.